Lower blood levels of amyloid-beta 42 during mid-life were associated with a higher risk of dementia and a marginally increased risk of mild cognitive impairment later in life, a new study reports.
A new DNA vaccine tested in mice significantly reduces tau and amyloid beta, two proteins implicated in Alzheimer's disease. The findings, researchers say, may pave the way for clinical trials in humans with the neurodegenerative disease.
Researchers investigate the role the BMI1 gene plays in the onset and development of Alzheimer's disease. The study reports the loss of BMI1 triggers and increased production of amyloid beta and decreases neural ability to eliminate the protein.
Alzheimer's linked protein, amyloid beta, appears to do very little harm to glial cells, at least in fruit flies, researchers report.
A new study reports on a surprising link between OSA and Alzheimer's disease. Researchers report people who suffer a number of apneas per hour have increased accumulation of amyloid beta in the brain over time.
Researchers have devised a new blood test that can detect if amyloid had begun to accumulate in the brain. The test help physicians diagnose Alzheimer's disease in a cheaper, less invasive way than currently available. The researchers will present their findings at the Alzheimer's Association International Conference in London.
Learning how to manipulate inflammatory conditions could help to develop new therapies to stimulate neurogenesis and protect against Alzheimer's, a new study suggests.
Researchers have crystallized a protein that could hold the answer as to how nicotine addiction occurs in the brain.
Reducing the production of exosomes may help slow the progression of Alzheimer's disease.
According to researchers, as we age, it takes a lot longer to clear amyloid beta from the brain, thus leading to a build up of the toxic protein implicated in Alzheimer's disease.